Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse
28 Mar 2024 //
GLOBENEWSWIRE
Endonovos SofPulse® to Be Featured at Innovative Pain Management Solutions
04 Mar 2024 //
GLOBENEWSWIRE
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business
04 Dec 2023 //
GLOBENEWSWIRE
Endonovo`s SofPulse® Secures Taiwan FDA Approval
12 Oct 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support